Literature DB >> 32619579

Determination of peripapillary vessel density in optic disc drusen using EDI-OCT and OCT angiography.

Anne-Sofie Wessel Lindberg1, Vedrana Andersen Dahl2, Isabelle Karlesand3, Lea Lybek Rueløkke3, Lasse Malmqvist3, Steffen Hamann3.   

Abstract

Optical coherence tomography angiography (OCTA) is a rapidly developing technique which generates angiographic images non-invasively. This study proposes a method to determine the vessel density in OCTA scans in general and especially the local peripapillary vessel density. The method produces vessel density heatmaps that contain information about the local vessel density. We apply the method in a small study to demonstrate its applicability and its potential to investigate the influence of local conditions on the vessel density. In the study, we combine information from enhanced depth imaging optical coherence tomography (EDI-OCT) about the location of optic disc drusen (ODD) with information from OCTA about the vessel density. We see a reduction in local peripapillary vessel density in peripapillary sections with a large volume of ODD.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical applications; Image analysis; Optic disc drusen; Optical coherence tomography; Optical coherence tomography angiography; Vessel density

Year:  2020        PMID: 32619579     DOI: 10.1016/j.exer.2020.108123

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

Review 1.  The current clinical role of optical coherence tomography angiography in neuro-ophthalmological diseases.

Authors:  Serdar Bilici; Reşat Duman
Journal:  Taiwan J Ophthalmol       Date:  2022-02-11

2.  Topographic Quadrant Analysis of Peripapillary Superficial Microvasculature in Optic Disc Drusen.

Authors:  Yan Yan; Xiao Zhou; Zhongdi Chu; Laurel Stell; Mohammad Ali Shariati; Ruikang K Wang; Yaping Joyce Liao
Journal:  Front Neurol       Date:  2021-05-19       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.